Blackstone’s Crescent Biopharma CBIO Stock Holding History
Bought
Maintained
Sold
Other funds holding CBIO
OM
Blackstone's CBIO Position: Q2 2026 in Review
Blackstone opened a new position in Crescent Biopharma (CBIO) in Q2 2026: 62,647 shares worth $1.13M. The stake represents ﹤0.01% of the portfolio and ranks #243 among its holdings. This is a return to the name: Blackstone previously reported a position in CBIO as recently as Q4 2025.
Blackstone first reported a position in CBIO in Q4 2014 and has held it in 5 quarters since. The position peaked at $1.22M in Q2 2025. 82 funds tracked by Wall St. Rank hold CBIO as of Q2 2026.
- Blackstone held 62,647 shares of Crescent Biopharma worth $1.13M as of Q2 2026.
- Crescent Biopharma was a new Blackstone position in Q2 2026.
- Crescent Biopharma made up ﹤0.01% of Blackstone's portfolio in Q2 2026, its #243 holding.
- Blackstone first reported a position in Crescent Biopharma in Q4 2014 and has held it in 5 quarters since.
- Blackstone's Crescent Biopharma position peaked at $1.22M in Q2 2025.
- 82 funds tracked by Wall St. Rank held Crescent Biopharma as of Q2 2026.
Based on Blackstone's 13F filing for Q2 2026, filed 14 Aug 2026.